Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News
  • Offerings

Reported Late Tuesday, Pliant Therapeutics Announces Pricing Of Upsized $250M Public Offering Of 8,333,334 Shares Of Common Stock At A Price Of $30/Share

By Benzinga Newsdesk
Today, 10:15 PM
Pliant Therapeutics, Inc. (NASDAQ:PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the pricing of an upsized

PLRX

Read More
1 minute read
  • News
  • Offerings

Digital Ally Files For Common Stock Offering, Size Not Disclosed

By Michael Horton
Today, 10:15 PM
-SEC Filing

DGLY

Read More
3 minute read
  • News
  • Offerings

enCore Energy Announces Proposed Public Offering; Size Not Disclosed

By Benzinga Newsdesk
Today, 10:15 PM
NYSE American:EU   CORPUS CHRISTI, Texas, Jan. 24, 2023 /CNW/ - enCore Energy Corp. ("enCore" or the "Company") (NYSE:EU) (TSXV:EU) today announced that it has filed a

EU

Read More
1 minute read
  • News
  • Offerings
  • Penny Stocks

LogicMark on Monday, Priced 10.585M Unit Underwritten Public Offering @$0.371/Unit

By Charles Gross
Today, 10:15 PM
LogicMark, Inc.

LGMK

Read More
2 minute read
  • News
  • Offerings

Reported Late Monday, PennantPark Floating Rate Capital Announces Pricing Of $47.6M Public Offering Of 4.25M Share Of Common Stock At A Price Of $11.20/Share

By Benzinga Newsdesk
Today, 10:15 PM
PennantPark Floating Rate Capital Ltd. (NYSE:PFLT) (TASE: PFLT), a business development company (the "Company"), today announced that it has entered into an agreement to sell 4,250,000 shares of common stock

PFLT

Read More
1 minute read
  • Management
  • News
  • Offerings

Genius Group CEO Roger James Hamilton Says Co. Is Not Planning Any Offering Of Stock At The Moment

By Benzinga Newsdesk
Today, 10:15 PM
- Benzinga Interview 

GNS

Read More
1 minute read
  • General
  • News
  • Offerings
  • Penny Stocks

China Jo-Jo Drugstores Raises $2.65M Via Equity Offering

By Shivani Kumaresan
Today, 10:15 PM
China Jo-Jo Drugstores Holdings Inc (NASDAQ:CJJD) has entered into definitive agreements with several investors providing for the issuance of 1.75 million…

CJJD

Read More
2 minute read
  • News
  • Offerings

Reported Late Thursday, Akoustis Announces Pricing Of $30M Public Offering Of 10,909,091 Shares Of Common Stock At A Price Of $2.75/Share

By Benzinga Newsdesk
Today, 10:15 PM
Akoustis Technologies, Inc. (Nasdaq: AKTS) ("Akoustis" or the "Company"), an integrated device manufacturer of patented bulk acoustic wave ("BAW") high-band radio frequency

AKTS

Read More
2 minute read
  • News
  • Offerings

Deciphera Pharmaceuticals Announces Pricing Of $125M Public Offering Of 6,944,445 Shares Of Common Stock At A Price Of $18/Share

By Benzinga Newsdesk
Today, 10:15 PM
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced the

DCPH

Read More
1 minute read
  • News
  • Offerings

NeuroSense Therapeutics Files For Mixed-Securities Shelf Offering Of Up To $100M

By Michael Horton
Today, 10:15 PM
-SEC Filing

NRSN

Posts navigation

Previous 1 … 18 19 20 … 178 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service